Table 4.
Serum concentrations of vitamin D metabolites in control (n 6) and treatment (n 7) groups as measured by HPLC at the conclusion of the vitamin D supplementation trial
(Mean values and standard deviations)
| Group | ||||
|---|---|---|---|---|
| Control | Treatment* | |||
| Vitamin D metabolite | Mean | sd | Mean | sd |
| 25(OH)D3 (ng/ml) | 40·4 | 9·9 | 47·8 | 6·4 |
| 25(OH)D2 (ng/ml) | ND | ND | ||
| 24R,25(OH)2D3 (ng/ml) | 17·7 | 6 | 18·5 | 3·7 |
25(OH)D3, 25-hydroxyvitamin D3; 25(OH)D2, 25-hydroxyvitamin D2; ND, not detected (<1·0 ng/ml); 24R,25(OH)2D3, 24R, 25-dihydroxyvitamin D3.
Daily oral vitamin D3 supplementation, 2·3 µg/kg0·75.